<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Advances in medicine &#187; Cancer</title>
	<atom:link href="http://www.advances-in-medicine.com/category/cancer/feed" rel="self" type="application/rss+xml" />
	<link>http://www.advances-in-medicine.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 18:12:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Bilateral Paramediastinal Post- Traumatic Lung Cysts: DISCUSSION</title>
		<link>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-discussion.html</link>
		<comments>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-discussion.html#comments</comments>
		<pubDate>Sun, 03 Apr 2011 04:39:32 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bilateral Paramediastinal]]></category>
		<category><![CDATA[Lung Cysts]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2549</guid>
		<description><![CDATA[To our knowledge, this case is the first report of bilateral post-traumatic paramediastinal lung cysts. Furthermore, it illustrates several characteristic features of this condition. All patients have a history of blunt chest trauma, which may be minor. Over 80 percent are 30 years of age or less, with no previous pulmonary complaints. Many patients present with [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bilateral Paramediastinal Post- Traumatic Lung Cysts: Case Report</title>
		<link>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-case-report.html</link>
		<comments>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-case-report.html#comments</comments>
		<pubDate>Fri, 01 Apr 2011 16:48:40 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bilateral Paramediastinal]]></category>
		<category><![CDATA[Lung Cysts]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2547</guid>
		<description><![CDATA[Case Report The patient was a 25-year-old white man with a history of intravenous drug abuse, bisexual behavior, HIV antibody-positive status, a perirectal abscess, hepatitis B, and recurrent lower- extremity staphylococcal infections, who presented to University Medical Center after a motorcycle accident. An emergency-room, portable chest roentgenogram was initially interpreted as revealing no gross abnormality [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2011/04/bilateral-paramediastinal-post-traumatic-lung-cysts-case-report.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bilateral Paramediastinal Post- Traumatic Lung Cysts</title>
		<link>http://www.advances-in-medicine.com/2011/03/bilateral-paramediastinal-post-traumatic-lung-cysts.html</link>
		<comments>http://www.advances-in-medicine.com/2011/03/bilateral-paramediastinal-post-traumatic-lung-cysts.html#comments</comments>
		<pubDate>Thu, 31 Mar 2011 10:35:42 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bilateral Paramediastinal]]></category>
		<category><![CDATA[Lung Cysts]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2546</guid>
		<description><![CDATA[Unilateral post-traumatic and paramediastinal lung cysts are uncommon and usually do not require treatment. Nevertheless, recognition of a traumatic lung cyst is impor­tant, since misdiagnosis may lead to unnecessary surgery. This report describes a patient whose bilateral post-trau­matic paramediastinal lung cysts were mistaken for hemi- diaphragmatic hernias. This unusual complication of blunt chest trauma has [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2011/03/bilateral-paramediastinal-post-traumatic-lung-cysts.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Society of Clinical Oncology: Standard Therapy plus Oxaliplatin for the Treatment of Colorectal Cancer</title>
		<link>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-standard-therapy-plus-oxaliplatin-for-the-treatment-of-colorectal-cancer.html</link>
		<comments>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-standard-therapy-plus-oxaliplatin-for-the-treatment-of-colorectal-cancer.html#comments</comments>
		<pubDate>Sun, 25 Apr 2010 15:00:54 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical Oncology]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1755</guid>
		<description><![CDATA[Speaker: Norman Wolmark, MD, Chairman and Professor, Department of Human Oncology, Drexel University College of Medicine and Allegheny Cancer Center, and Chairman of the National Surgical Adjuvant Breast and Bowel Project. The addition of oxaliplatin (Eloxatin®, Sanofi-Aventis) to standard fluorouracil (5-FU) (Efudex®, Roche)/leucovorin (LV) (Wellcovorin®, Immunex) therapy (FULV) significantly improved three-year disease-free survival in patients [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-standard-therapy-plus-oxaliplatin-for-the-treatment-of-colorectal-cancer.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Society of Clinical Oncology: Oblimersen Sodium for Advanced Malignant Melanoma</title>
		<link>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-oblimersen-sodium-for-advanced-malignant-melanoma.html</link>
		<comments>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-oblimersen-sodium-for-advanced-malignant-melanoma.html#comments</comments>
		<pubDate>Sat, 24 Apr 2010 15:00:54 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical Oncology]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1754</guid>
		<description><![CDATA[Speaker: John Kirkwood, Professor of Medicine and Director, the Melanoma Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. Long-term follow-up results for a minimum of 24 months demonstrated that adding oblimersen sodium (Genasense®, Genta), also called Bcl-2 antisense, to dacarbazine (DTIC-Dome®, Bayer)—the only chemotherapy agent approved for the treatment of advanced melanoma—achieved a significant increase [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-oblimersen-sodium-for-advanced-malignant-melanoma.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Society of Clinical Oncology: Zolendronic Acid and Bone Mass in Women with Breast Cancer</title>
		<link>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-zolendronic-acid-and-bone-mass-in-women-with-breast-cancer.html</link>
		<comments>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-zolendronic-acid-and-bone-mass-in-women-with-breast-cancer.html#comments</comments>
		<pubDate>Fri, 23 Apr 2010 15:00:52 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical Oncology]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1753</guid>
		<description><![CDATA[Speaker: Adam Brufsky, MD, PhD, Co-Director, Magee Women&#8217;s Hospital/University of Pittsburgh Cancer Institute, Comprehensive Breast Cancer Center, and Assistant Professor of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. &#8220;Up-front&#8221; zolendronic acid (Zometa®, Novartis), an intravenous (IV) bisphosphonate, when given with adjuvant letrozole (Generic Femara, Novartis) therapy, was able to inhibit bone loss in postmenopausal women with [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-zolendronic-acid-and-bone-mass-in-women-with-breast-cancer.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Society of Clinical Oncology</title>
		<link>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-2.html</link>
		<comments>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-2.html#comments</comments>
		<pubDate>Thu, 22 Apr 2010 15:27:27 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical Oncology]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1752</guid>
		<description><![CDATA[Anastrozole in Localized Breast Cancer Speaker: David Cella, PhD, Director of Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare, and Professor, Northwestern University Medical School, Evanston, Illinois. A five-year quality-of-life (QOL) follow-up study of adjuvant endocrine therapy for postmenopausal women with early breast cancer in the Arimidex or Tamoxifen Alone or in Combination [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/04/american-society-of-clinical-oncology-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

